AnterixATEX
Fair Value
US$44
Share price05 Jan
US$104.92138.5% overvalued intrinsic discount
1Y328.59%
7D-3.04%
Unmonetized Spectrum And Slow Utility Adoption Will Eventually Support Long Term Potential
AN
Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.
Published
05 Jan 26
Views
30
Not Invested